Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

FDA approves IVAX drug for IC

Oct. 4, 1996

Glaxo Wellcome reports new diuretics

Oct. 4, 1996

Yamanouchi reports agent for urinary incontinence

Sep. 27, 1996

NC-1800 advances through clinical trials

Sep. 20, 1996

New agents for BPH from Abbott

Sep. 20, 1996

Merck & Co. continues to investigate 5alpha-reductase inhibitors

Sep. 20, 1996

Development of VML-252 progresses

Sep. 13, 1996

Cimetidine for treatment of interstitial cystitis

Sep. 6, 1996

Darifenacin for urge incontinence

Sep. 6, 1996

Potential use for YM-934 in bladder hypersensitivity

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 9, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
FDA clears path for Boston Sci’s Bolt IVL to challenge J&J’s Shockwave
BioWorld MedTech
Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular...
ADPD 2025: Novel treatment modalities in neurodegenerative disorders
BioWorld Science
The current treatment strategies for neurodegenerative diseases focus on targeting Aβ in Alzheimer’s disease (AD), α-synuclein aggregates in Parkinson’s disease...